6 is the total number of securities SR ONE CAPITAL MANAGEMENT, LP has owned. The longest SR ONE CAPITAL MANAGEMENT, LP has owned a single stock is 8 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| DSGN | DESIGN THERAPEUTICS INC | 8 | 8 | 7.89% | 32.53% | 68.08% | Q4 2021 | Q3 2023 | 8 |
| EFFECTOR THERAPEUTICS INC | 8 | 8 | 0.89% | 7.36% | 31.92% | Q4 2021 | Q3 2023 | 8 | |
| ARCELLX INC. | 7 | 7 | 39.48% | 55.29% | 72.57% | Q1 2022 | Q3 2023 | 7 | |
| NKTX | NKARTA INC. | 6 | 6 | 0.95% | 3.82% | 8.04% | Q2 2022 | Q3 2023 | 6 |
| SBTX | ARS PHARMACEUTICALS INC | 4 | 4 | 7.77% | 9.62% | 11.59% | Q4 2022 | Q3 2023 | 4 |
| MINERALYS THERAPEUTICS... | 3 | 3 | 8.75% | 10.80% | 13.19% | Q1 2023 | Q3 2023 | 3 | |
Download | |||||||||
The securities at the top of the list , including DESIGN THERAPEUTICS INC, EFFECTOR THERAPEUTICS INC, and ARCELLX INC., are the highest-conviction holdings of SR ONE CAPITAL MANAGEMENT, LP.
The conviction is calculated by counting the number of quarters a security has been reported by SR ONE CAPITAL MANAGEMENT, LP. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that SR ONE CAPITAL MANAGEMENT, LP owns currently or has owned in the past.